← Back to headlines
Amgen and AstraZeneca Report Late-Stage Trial Success for Asthma Drug Tezspire
Pharmaceutical partners Amgen and AstraZeneca announced positive late-stage clinical trial results for Tezspire, demonstrating efficacy in treating a related swallowing disorder beyond its approved asthma indication.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon Cargo Plane Overshoots Miami Runway, Killing At Least Five People
34m ago
Japan’s Foreign Reserves Plunge Record $79.6 Billion After Yen Intervention
37m ago
Record-Breaking White Falcon Fetches 2.1 Million Dirhams at Abu Dhabi Auction
41m ago
China Pumps Over $100 Billion into State Banks and Insurers to Stabilize Economy
48m ago